165 related articles for article (PubMed ID: 36765805)
1. Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions.
Qiu L; Wang SA; Tang G; Wang W; Lin P; Xu J; Yin CC; Khanlari M; Medeiros LJ; Li S
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765805
[TBL] [Abstract][Full Text] [Related]
2. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.
Khanlari M; Medeiros LJ; Lin P; Xu J; You MJ; Tang G; Yin CC; Wang W; Qiu L; Miranda RN; Bueso-Ramos CE; Li S
Mod Pathol; 2022 Mar; 35(3):419-426. PubMed ID: 34608246
[TBL] [Abstract][Full Text] [Related]
3. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with
Uchida A; Isobe Y; Uemura Y; Nishio Y; Sakai H; Kato M; Otsubo K; Hoshikawa M; Takagi M; Miura I
BMC Clin Pathol; 2017; 17():21. PubMed ID: 29151814
[TBL] [Abstract][Full Text] [Related]
4. Defining and treating high-grade B-cell lymphoma, NOS.
Olszewski AJ; Kurt H; Evens AM
Blood; 2022 Sep; 140(9):943-954. PubMed ID: 34525177
[TBL] [Abstract][Full Text] [Related]
5. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis.
Kanagal-Shamanna R; Medeiros LJ; Lu G; Wang SA; Manning JT; Lin P; Penn GM; Young KH; You MJ; Vega F; Bassett R; Miranda RN
Histopathology; 2012 Nov; 61(5):945-54. PubMed ID: 22804688
[TBL] [Abstract][Full Text] [Related]
6. Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.
Chiu A; Frizzera G; Mathew S; Hyjek EM; Chadburn A; Tam W; Knowles DM; Orazi A
Mod Pathol; 2009 Nov; 22(11):1507-17. PubMed ID: 19633642
[TBL] [Abstract][Full Text] [Related]
7. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
8. Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses.
Zanelli M; Sanguedolce F; Zizzo M; Fragliasso V; Broggi G; Palicelli A; Loscocco GG; Cresta C; Caprera C; Corsi M; Martino G; Bisagni A; Marchetti M; Koufopoulos N; Parente P; Caltabiano R; Ascani S
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568745
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic findings in blastoid mantle cell lymphoma.
Khoury JD; Sen F; Abruzzo LV; Hayes K; Glassman A; Medeiros LJ
Hum Pathol; 2003 Oct; 34(10):1022-9. PubMed ID: 14608536
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
11. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
Soslow RA; Zukerberg LR; Harris NL; Warnke RA
Mod Pathol; 1997 Aug; 10(8):810-7. PubMed ID: 9267824
[TBL] [Abstract][Full Text] [Related]
12. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements].
Shen X; Zhou LT; Li AQ; Yi HM; Ouyang BS; Xu HM; Xie JL; Gu YJ; Zhang L; Dong L
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):120-125. PubMed ID: 35152630
[No Abstract] [Full Text] [Related]
14. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers.
Almeida R; Abrantes C; Gigliano D; Oliveira RC; Teixeira P; Viegas M; Rodrigues Â; Julião MJ
Int J Hematol Oncol Stem Cell Res; 2022 Apr; 16(2):94-102. PubMed ID: 36304730
[No Abstract] [Full Text] [Related]
16. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
17. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
18. Blastoid Variant of Mantle Cell Lymphoma with Leukemic Presentation - A Rare Case Report.
Khanna R; Belurkar S; Lavanya P; Manohar C; Valiathan M
J Clin Diagn Res; 2017 Apr; 11(4):ED16-ED18. PubMed ID: 28571156
[TBL] [Abstract][Full Text] [Related]
19. Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
Kuhlman JJ; Moustafa MA; Jiang L; Iqbal M; Seegobin K; Wolcott Z; Ayala E; Ansell S; Rosenthal A; Paludo J; Micallef I; Johnston P; Inwards D; Habermann T; Kharfan-Dabaja M; Witzig TE; Nowakowski GS; Tun HW
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e815-e825. PubMed ID: 35534379
[TBL] [Abstract][Full Text] [Related]
20. A large single-institution retrospective analysis of aggressive B-cell lymphomas according to the 2016/2017 WHO classification.
Jesionek-Kupnicka D; Braun M; Robak T; Kuncman W; Kordek R
Adv Clin Exp Med; 2019 Oct; 28(10):1359-1365. PubMed ID: 31518494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
